苯扎贝特对血清脂蛋白脂质和载脂蛋白组成、脂蛋白甘油三酯清除能力及血浆脂质酯脂肪酸组成的影响。 - Suppr

Suppr

超能文献

Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters.

作者信息

Vessby B, Lithell H, Hellsing K, Ostlund-Lindqvist A M, Gustafsson I B, Boberg J, Ledermann H

出版信息

Atherosclerosis. 1980 Oct;37(2):257-69. doi: 10.1016/0021-9150(80)90011-8.

DOI:10.1016/0021-9150(80)90011-8

PMID:7000090

Abstract

摘要

相似文献

Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters.苯扎贝特对血清脂蛋白脂质和载脂蛋白组成、脂蛋白甘油三酯清除能力及血浆脂质酯脂肪酸组成的影响。

Atherosclerosis. 1980 Oct;37(2):257-69. doi: 10.1016/0021-9150(80)90011-8.

Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.非诺贝特对高脂血症非胰岛素依赖型糖尿病患者血浆脂质、脂蛋白、载脂蛋白AI、AII、B及卵磷脂胆固醇酰基转移酶活性的影响

Atherosclerosis. 1982 Jun;43(2-3):321-7. doi: 10.1016/0021-9150(82)90032-6.

Reduced LDL- and increased HDL-apoproteins in patients with hypercholesterolaemia under treatment with bezafibrate.接受苯扎贝特治疗的高胆固醇血症患者低密度脂蛋白降低，高密度脂蛋白载脂蛋白升高。

Atherosclerosis. 1981 Oct;40(2):153-8. doi: 10.1016/0021-9150(81)90033-2.

Effects of bezafibrate on the composition of very low density lipoproteins in type IV hyperlipoproteinemia.

Atherosclerosis. 1982 Apr;42(2-3):245-9. doi: 10.1016/0021-9150(82)90154-x.

Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects.

Atherosclerosis. 1982 Sep;44(3):355-65. doi: 10.1016/0021-9150(82)90010-7.

Effect of bezafibrate on the high-density lipoprotein subfractions HDL2 and HDL3 in primary hyperlipoproteinemia type IV.苯扎贝特对IV型原发性高脂蛋白血症中高密度脂蛋白亚组分HDL2和HDL3的影响。

Artery. 1980;7(6):464-70.

Treatment of familial hypercholesterolemia with a combination of bezafibrate and guar.

Atherosclerosis. 1982 Dec;45(3):291-7. doi: 10.1016/0021-9150(82)90230-1.

[Bezafibrate and delayed action etofibrate in hyperlipidemia].[非诺贝特与缓释依托贝特治疗高脂血症]

Dtsch Med Wochenschr. 1983 Feb 25;108(8):302-5. doi: 10.1055/s-2008-1069545.

Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.环丙贝特对高脂蛋白血症患者血清脂蛋白浓度影响的剂量反应研究。

Atherosclerosis. 1982 Apr;42(2-3):229-43. doi: 10.1016/0021-9150(82)90153-8.

Treatment of uremic hypertriglyceridaemia with bezafibrate.用苯扎贝特治疗尿毒症性高甘油三酯血症。

Atherosclerosis. 1982 Aug;44(2):125-36. doi: 10.1016/0021-9150(82)90107-1.

引用本文的文献

Bezafibrate for primary biliary cirrhosis.苯扎贝特用于原发性胆汁性肝硬化

Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD009145. doi: 10.1002/14651858.CD009145.pub2.

Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate.抗高血脂药物苯扎贝特对荷瘤状态下脂蛋白脂肪酶活性降低的刺激作用。

Surg Today. 1996;26(2):89-94. doi: 10.1007/BF00311770.

Decreased susceptibility to copper-induced oxidation of rat-lipoproteins after fibrate treatment: influence of fatty acid composition.贝特类药物治疗后大鼠脂蛋白对铜诱导氧化的敏感性降低：脂肪酸组成的影响。

Br J Pharmacol. 1996 Mar;117(6):1155-62. doi: 10.1111/j.1476-5381.1996.tb16710.x.

Iatrogenic profound hypoalphalipoproteinaemia: an unrecognised cause of very low HDL cholesterol.医源性严重低α脂蛋白血症：高密度脂蛋白胆固醇极低的一个未被认识的原因。

Postgrad Med J. 1995 Aug;71(838):498-500. doi: 10.1136/pgmj.71.838.498.

Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.氯贝丁酯、苯扎贝特、非诺贝特及普罗布考对血脂正常受试者血浆脂解酶的影响。

Eur J Clin Pharmacol. 1983;25(1):57-63. doi: 10.1007/BF00544015.

Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects.非诺贝特治疗高甘油三酯血症患者期间载脂蛋白A和B（Sf 100 - 400）的代谢

J Clin Invest. 1984 Dec;74(6):2164-77. doi: 10.1172/JCI111643.

Increased high density lipoproteins in diabetic children.糖尿病儿童中高密度脂蛋白增加。

Eur J Pediatr. 1984 Aug;142(3):154-6. doi: 10.1007/BF00442440.

The short term effects of bezafibrate on the hypertriglyceridaemia of moderate to severe uraemia.苯扎贝特对中重度尿毒症高甘油三酯血症的短期影响。

Br J Clin Pharmacol. 1984 Sep;18(3):361-7. doi: 10.1111/j.1365-2125.1984.tb02477.x.

Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemia.苯扎贝特。对其药效学和药代动力学特性以及在高脂血症治疗中的应用的综述。

Drugs. 1987 Jun;33(6):539-76. doi: 10.2165/00003495-198733060-00002.

Effects of long-term ketoconazole therapy on serum lipid levels.

Eur J Clin Pharmacol. 1985;29(2):241-5. doi: 10.1007/BF00547430.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验